 |
|
|
| |
Effect of Baseline Resistance-Associated Variants on SVR With the 3D Regimen Plus RBV
|
| |
| |
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Mark Sulkowski1, Preethi Krishnan2, Rakesh Tripathi2, Gretja Schnell2, Yan Xie2, Daniel E Cohen2, Roger Trinh2, Nancy S Shulman2, Tami Pilot-Mati as2, Christi ne Collins2
1Viral Hepatitis Center, Johns Hopkins University, Baltimore, Maryland, United States; 2AbbVie Inc., North Chicago, Illinois, United States
|
| |
|
|
|
|
|
